Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2004-03-22
2009-11-03
Carr, Deborah D (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S547000, C514S458000, C514S560000, C514S825000, C514S900000, C514S902000, C424S769000
Reexamination Certificate
active
07612111
ABSTRACT:
The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
REFERENCES:
patent: 4330557 (1982-05-01), Cavazza
patent: 4454159 (1984-06-01), Musher
patent: 5569676 (1996-10-01), Diehl
patent: 6417227 (2002-07-01), Lord et al.
patent: 0 937 394 (1999-08-01), None
patent: 64-30818 (1989-02-01), None
patent: 01/38288 (2001-05-01), None
patent: WO 01/85162 (2001-11-01), None
Chem. Abstr. of IT-1302626.
Perneger et al, “Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs”,The New England Journal of Medicine, Dec. 22, 1994, vol. 331:1675-1679, No. 25; Massachusetts Medical Society, Boston, Massachusetts.
“Impact of Arthritis and Other Rheumatic Conditions 1997”, MMWR, May 7, 1999, 48(17);349-353, Centers for Disease Control and Preventoin, Atlanta, Georgia.
Wilcox et al., “Striking Prevalence of Over-the-Counter Nonsteroidal Anti-inflammatory Drug Use in Patients with Upper Gastrointestinal Hemorrhage”,Archives of Internal Medicine, Jan. 10, 1994, vol. 154, No. 1, American Medical Association, Chicago, Illinois.
Curtis et al., “n-3 Fatty Acids Specifically Modulate Catabolic Factors Involved in Articular Cartilage Degradation”,J. Biol Chem, Jan. 14, 2000, vol. 275, Issue 2, pp. 721-724, American Society for Biochemistry and Molecular Biology, Bethesda, Maryland.
Everts et al., “Cox-2-Specific Inhibitors—the Emergence of a New Class of Analgesic and Anti-inflammatory Drugs”,Clinical Rheumatology, 2000, 19:331-43, Elsevier, Oxford, United Kingdom.
Kremer, Effects of Modulation of Inflammatory and Immune Parameters in Patients with Rheumatic and Inflammatory Disease Receiving Dietary Supplementation of n-3 and n-6 Fatty Acids,Lipids, 1996, 31 Supp: S-243-S-247, American Oil Chemists Society, Chicago, Illinois.
International Search Report dated Oct. 16, 2004.
Written Opinion.
Hasturk et al., “1-Tetradecanol Complex Reduces Progression ofPorphyromonas gingivalis-Induced Experimental Periodontitis in Rabbits,”Periodontol, 2007, vol. 78, No. 5, pp. 1-9.
Heasman et al., “The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease,” J. Clin. Periodontol 1993; 20:457-464.
Pihlstrom et al., “Periodontal risk assessment, diagnosis and treatment planning,” Periodontol 2000, 2001, 25:37-58.
Diehl, Harry W. et al. “Cetyl Myrstoleate Isolated from Swiss Albino Mice: An Apparent Protective Agent against Adjuvant Arthritis in Rats,” Journal of Pharmaceutical Sciences, 83:3, 296-299 (1994).
European Supplementary Search Report issued Aug. 27, 2008 in EP04757977.6.
Millsap Patrick S.
Spencer William P.
Carr Deborah D
Imagenetix, Inc.
Tahmassebi Sam K.
TechLaw LLP
LandOfFree
Esterified fatty acid composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esterified fatty acid composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esterified fatty acid composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4140878